Dr, SANJAY KUMAR BHARTI

Assistant Professor

Work Experience

14 years

Area of Specialization

Pharmaceutical Chemistry

Projects & Patents

Design and synthesis of some novel metal (Co, Ni, Ga) complexes of bi-/tridentate ligand(s) as potential nucleolytic and anticancer agents (UGC-STARTUP, Worth: 6 Lakhs, Duration:2 Years); (Sanctioned Date: March 30, 2013, Completed date: March 30, 2015)

Education

M. Pharm., Ph.D.

Achievments/Awards/Honors

• Merit-Cum-Means Scholarship in Bachelor of Pharmacy (B. Pharm.), (I.T.-B.H.U.). • Qualified GATE (Graduate Aptitude Test in Engineering (Pharmaceutical sciences), conducted by Indian Institute of Technology (IIT), Madras with a percentile score of 93.14 and All India Rank- 434 (2003). • GATE Scholarship (JRF) in Master of Pharmacy (M. Pharm.) from AICTE, New Delhi. • Senior Research Fellowship (SRF) in Ph.D., UGC, New Delhi. • Venus International Foundation awarded “Outstanding Researcher in Pharmaceutical Chemistry” on 21-09-2019. • Listed in World’s Top 2% Scientists, published by Stanford University, USA (2021)

Publications

41. Asati Vivek*, Anant Arjun, Mahapatra Kar Debarshi and Bharti Kumar Sanjay*, Recent advances of PI3 Kinase inhibitors: Structure anticancer activity relationship studies, Mini-Reviews in Medicinal Chemistry 2022; 22(16): 2146 - 2165 (Bentham Science Publication, Impact Factor-3.862). (ISSN: 1389-5575 print; 1875-5607online) 40. Vivek Asati, Sanjay K. Bharti, Ratnesh Das, Varsha Kashaw & Sushil Kumar Kashaw (2022) Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: A computational study, Journal of Biomolecular Structure and Dynamics, 40:20, 10422-10436, DOI: 10.1080/07391102.2021.1944320 (Taylor & Francis Publication, Impact Factor: 5.23) (ISSN: Print ISSN: 0739-1102 Online ISSN: 1538-0254) 39. Debarshi Kar Mahapatra, Soumajit Ghorai, Sanjay Kumar Bharti, Asmita Gajbhiye Patil and Shovanlal Gayen, Current discovery progress of some emerging anti-infective chalcones: Highlights from 2016 to 2017, Current Drug Discovery Technologies 2020;17(1):30-44 (Bentham Science Publication)(ISSN:1875-6220, Online; 15701638, Print). 38. Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti*, An updated patent review of therapeutic applications of chalcone derivatives (2014-present), Expert Opinion on Therapeutic Patents (2019) 29(5):385-406 (Taylor & Francis Publication; Impact factor: 6.674) (ISSN:1354-3776; Print) 37. Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Vivek Asati, Sushil Kumar Singh, Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications. European Journal of Medicinal Chemistry (2019) 174:142-158 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 36. Vivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, PIM Kinase Inhibitors: Structural and Pharmacological Perspectives. European Journal of Medicinal Chemistry (2019) 172: 95-108 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 35. Vivek Asati, Piyush Ghode, Shalini Bajaj, Sanmati Kumar Jain, Sanjay Kumar Bharti*, 3D-QSAR and molecular docking studies on oxadiazole substituted benzimidazole derivatives: Validation of experimental inhibitory potencies towards COX-2, Current Computer Aided Drug Design, (2019) 15(4):277-293 (Bentham Science Publication, Impact Factor: 1.606) (ISSN: 1875-6697). 34. Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti, Recent therapeutic progress of chalcone scaffold bearing compounds as prospective anti-gout candidates, Journal of Critical Reviews (2019)6(1):1-5 (ISSN- 2394-5125). 33. Vivek Asati, Santosh S. Thakur, Neeraj Upmanyu, Sanjay Kumar Bharti*, Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine-2,4-diones as Potential PIM-1 Kinase Inhibitors, ChemistrySelect (2018) 3:12186-12194 (Wiley Online Library, Impact Factor:2.109) (Online ISSN: 2365-6549). 32. Vivek Asati, Sanjay Kumar Bharti*, Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents, Journal of Molecular Structure (2018)1154:406-417 (ELSEVIER Publication; Impact Factor: 3.196) (ISSN: 0022-2860). 31. Debarshi Kar Mahapatra, Vivek Asati and Sanjay Kumar Bharti*, MEK inhibitors in oncology: a patent review (2015-Present), Expert Opinion on Therapeutic Patents (2017) 27(8):887-906 (Taylor & Francis Publication; Impact factor: 6.674) (ISSN:1354-3776; Print). 30. Debarshi Kar Mahapatra, Sanjay Kumar Bharti* and Vivek Asati, Chalcone derivatives: anti-inflammatory potential and molecular targets perspectives, Current Topics in Medicinal Chemistry (2017)17(28):3146-3169 (Bentham Science Publication, Impact Factor: 3.295) (ISSN: 1873-4294). 29. Debarshi Kar Mahapatra*, Sanjay Kumar Bharti, Vivek Asati, Nature inspired green fabrication technology for silver nanoparticles, Current Nanomedicine (2017) 7(1):5-24 (Bentham Science Publication) (ISSN: 2468-1881). 28. Vivek Asati, Debarshi Kar Mahapatra and Sanjay Kumar Bharti*, K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives, European Journal of Medicinal Chemistry (2017) 125: 299-314 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 27. Vivek Asati, Sanjay Kumar Bharti, Ashok Kumar Budhwani, 3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase, Journal of Molecular Structure (2017) 11335: 278-293 (ELSEVIER Publication, Impact Factor: 3.196) (ISSN: 0022-2860). 26. Vivek Asati, Sanjay Kumar Bharti, Ankita Rathore, Debarshi Kar Mahapatra, SWFB and GA strategies for variable selection in QSAR studies for the validation of thiazolidine-2,4-dione derivatives as promising antitumor candidates, Indian Journal of Pharmaceutical Education and Research (2017) 51(3):436-451 (ISSN: 0019-5464). Impact Factor: 0.425 25. Debarshi Kar Mahapatra, Ruchi S. Shivhare, Sanjay K. Bharti, Novel Murrayanine based Pyrazole analogs as emerging anti-fungal candidates: Design, synthesis, characterization, and in vitro evaluation, Research Pharmaceutica (2017) 1(1): 01-05 (ISSN: 2457-0389 (Online) 24. Vivek Asati, Shalini Bajaj, Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Molecular Modeling Studies of Some Thiazolidine-2, 4-dione Derivatives as 15-PGDH Inhibitors, Medicinal Chemistry Research (2016), 25(1):94-108 (SPRINGER Publication, Impact factor-2.35) (ISSN: 1054-2523). 23. Vivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, PI3K/Akt/mTOR and Ras/Raf/MEK/ERK Signaling Pathways Inhibitors as Anticancer Agents: Structural and Pharmacological Perspectives, European Journal of Medicinal Chemistry (2016) 109:314-341 (ELSEVIER Publication, Impact Factor- 6.514) (ISSN: 0223-5234). 22. Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Therapeutic Potential of Chalcones as Cardiovascular Agents, Life Science (2016), 148: 154–172 (ELSEVIER Publication, Impact Factor: 3.44) (ISSN: 0024-3205). 21. Vivek Asati*, Sanjay Kumar Bharti, QSAR studies for some thiazolidine-2,4-dione derivatives as PIM-2 kinase inhibitors, Medicinal Chemistry Research (2016) 25(7): 1329-1339 (SPRINGER Publication, Impact Factor: 2.35) (ISSN: 1054-2523). 20. Vivek Asati*, Sanjay Kumar Bharti, Debarshi Kar Mahapatra, Mutant B-Raf Kinase inhibitors as anticancer agents, Anti-cancer agents in medicinal chemistry (2016) 16(12): 1558-1575 (Bentham Science Publication, Impact Factor: 2.18) ISSN: 1875-5992 (Online) ISSN: 1871-5206 (Print). 19. Vivek Asati*, Sanjay Kumar Bharti, Debarshi Kar Mahapatra, Ashok Kumar Budhwani, Triggering PIK3CA mutations in PI3K/AKT/mTOR axis: Exploration of newer inhibitors and rational preventive strategies, Current Pharmaceutical Design (2016) 22(39):6039-6054 (Bentham Science Publication, Impact Factor: 3.116) ISSN: 1873-4286 (Online) ISSN: 1381-6128 (Print). 18. Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Vivek Asati, Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives, European Journal of Medicinal Chemistry (2015)101:496-524 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 17. Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Vivek Asati, Anti-cancer chalcones: Structural and molecular target perspectives, European Journal of Medicinal Chemistry (2015)98:69-114 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 16. Debarshi Kar Mahapatra, Vivek Asati, Sanjay K. Bharti*, Chalcones and Their Therapeutic Targets for the Management of Diabetes: Structural and Pharmacological Perspectives, European Journal of Medicinal Chemistry (2015)92:839-865 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 15. Mukesh Kumar Gupta, J.S. Dangi, Sanjay Kumar Bharti, Mutations in surface protein of swine flu: A major problem for H1N1 inhibitor, Asian Journal of Biomedical and Pharmaceutical Sciences (2015)5(50):01-09 (ISSN: 2249 – 622X) 14. Vivek Asati, Debarshi Kar Mahapatra, Sanjay K. Bharti*, Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents, European Journal of Medicinal Chemistry (2014) 87: 814 – 833 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 13. Sanjay K. Bharti*, Sushil K. Singh, Design, synthesis and biological evaluation of some novel benzylidene-2-(4-phenylthiazol-2-yl) hydrazines as potential anti-inflammatory agents, Medicinal Chemistry Research (2014) 23:1004-1015 (SPRINGER Publication, Impact factor-2.35). (ISSN: 1054-2523). 12. Mukesh Kumar Gupta, Jawahar Singh Dangi, Sanjay Kumar Bharti, Krisna Gopal P, Drug of choice for swine flu: a challenge ahead, Asian Journal Of Pharmaceutical Sciences and Research (2013)3(6):01-18 (ISSN: ISSN 2249 - 4898). 11. C. Saravanan, Sanjay Kumar Bharti, S. Jaggi, S. K. Singh*, Histamine H4 Receptor: A Novel Target for Inflammation Therapy, Mini-Reviews in Medicinal Chemistry (2011) 11:143 - 158 (Bentham Science Publication, Impact Factor-3.862). (ISSN: 1389-5575 print; 1875-5607online) 10. Ajay Verma*, Tanu Khurana, Sanjay Kumar Bharti, Pharmacogeomics in clinical research and practice: An ethical consideration, Pharmacologyonline, 1 (2011) 453-461 (ISSN: 1827-8620). 11. Ashish Sethi, Rakesh Kumar Sharma, Sanjay Kumar Bharti*, Homology modeling and molecular dynamics study of serine hydroxyl methyl transferase enzyme from Leishmania donovani, Journal of Pharmacy Research (2011) 4 (7): 2269-2272 (ISSN: 0974-6943) 9. Sanjay Kumar Bharti, Saurabh K. Patel, Gopal Nath, Ragini Tilak, Sushil K. Singh*, Synthesis, characterization, DNA cleavage and in vitro antimicrobial activities of novel copper(II) complexes of Schiff bases containing a 2,4-disubstituted thiazole, Transition Metal Chemistry (2010) 35:917 – 925 (Springer Publication, Impact factor:1.588) ISSN: 0340-4285 (Print) 1572-901X (Online). 8. Sanjay Kumar Bharti, G. Nath, R. Tilak and S. K. Singh*, Synthesis, antibacterial and antifungal activities of some novel Schiff bases containing 2, 4-disubstituted thiazole ring, European Journal of Medicinal Chemistry (2010) 45: 651 – 660 (ELSEVIER Publication, Impact Factor: 6.514) (ISSN: 0223-5234). 7. Hemendra Singh Chouhan, Sanjay Kumar Bharti, Sushil K. Singh, 2D – Quantitative Structure Property Relationship (QSPR) Study of N-(aryl)-2-thiophen-2-ylacetamide Derivatives as Antitubercular Agents, Asian Journal of Chemistry (2010) 22: 4675-4680 ISSN: 0975-427X (Online); ISSN: 0970-7077 (Print) 6. S. K. Singh*, S. Jaggi, Sanjay Kumar Bharti and R. G. Kulkarni, Synthesis and Evaluation of N-Mannich bases of Isatin-3- (4- aldehyde/ketone 2-thiosemicarbazones) derivatives as potent anticonvulsant agents, Acta Pharmaceutica Sciencia (2009) 51(1): 47-55. (ISSN: 1307-2080) 4. Sanjay Kumar Bharti* and Sushil K. Singh, Metal Based Drugs: Current Use and Future Potential, Der Pharmacia Lettre 1 (2009) 39-51. (ISSN: 09755071) 3. Sanjay Kumar Bharti* and Sushil K. Singh, Recent developments in the field of anticancer metallopharmaceuticals, International Journal of PharmTech Research, 1 (2009) 1406-1420 (ISSN: 09744304) 2. S. K. Singh*, T. Prabha, B. Kavitha, H. S. Chouhan and Sanjay Kumar Bharti, Antidepressant activity of ethanolic extract of Euphorbia thymifolia Linn. in the forced swimming test in rats, Pharmacologyonline 2 (2009) 967-970 (ISSN: 1827-8620). 1. S. K. Singh*, T. Prabha, B. Kavitha, H. S. Chouhan and Sanjay Kumar Bharti, Anti-inflammatory and Hepatoprotective activities of ethanolic extract of Euphorbia thymifolia Linn., Pharmacologyonline 1 (2009) 986-994 (ISSN: 1827-8620). *Corresponding Author